Literature DB >> 16847422

Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.

Lindsay M Morton1, Maryjean Schenk, David W Hein, Scott Davis, Shelia Hoar Zahm, Wendy Cozen, James R Cerhan, Patricia Hartge, Robert Welch, Stephen J Chanock, Nathaniel Rothman, Sophia S Wang.   

Abstract

Animal studies suggest that lymphomagenesis can be induced by exposure to carcinogenic aromatic and heterocyclic amines found in diet, cigarette smoke and the environment, but human epidemiologic investigations of these exogenous exposures have yielded conflicting results. As part of our evaluation of the role of aromatic and heterocyclic amines, which are metabolized by N-acetyltransferase (NAT) enzymes, in the etiology of non-Hodgkin lymphoma (NHL), we examined NHL risk in relation to genetic variation in NAT1 and NAT2 and exposure to cigarette smoke and dietary heterocyclic amines and mutagens. We genotyped 10 common single nucleotide polymorphisms (SNPs) in NAT1 and NAT2 among 1136 cases and 922 controls from a population-based case-control study in four geographical areas of the USA. Relative risk of NHL for NAT1 and NAT2 genotypes, NAT2 acetylation phenotype, and exposure to cigarette smoke and dietary heterocyclic amines and mutagens was estimated using odds ratios (ORs) and 95% confidence intervals (CIs) derived from unconditional logistic regression models. We observed increased risk of NHL among individuals with the NAT1*10/*10 genotype compared with individuals with other NAT1 genotypes (OR = 1.60, 95% CI = 1.04-2.46, P = 0.03). We also observed increased NHL risk in a dose-dependent model among NAT2 intermediate- and rapid-acetylators compared with slow-acetylators, although only the trend was statistically significant (intermediate: OR = 1.18, 95% CI = 0.97-1.44, P = 0.1; rapid: OR = 1.43, 95% CI = 0.97-2.14, P = 0.07; P for linear trend = 0.03). Compared with non-smokers, NHL risk estimates for current cigarette smoking were increased only among NAT2 intermediate/rapid-acetylators (OR = 2.44, 95% CI = 1.15-5.20, P = 0.02). Our data provide evidence that NAT1 and NAT2 genotypes are associated with NHL risk and support a contributory role for carcinogenic aromatic and/or heterocyclic amines in the multi-factorial etiology of NHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847422      PMCID: PMC1986787          DOI: 10.1097/01.fpc.0000215071.59836.29

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  36 in total

1.  Genetic variation and willingness to participate in epidemiologic research: data from three studies.

Authors:  Parveen Bhatti; Alice J Sigurdson; Sophia S Wang; Jinbo Chen; Nathaniel Rothman; Patricia Hartge; Andrew W Bergen; Maria Teresa Landi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

Review 2.  Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph).

Authors:  Lindsay M Morton; Patricia Hartge; Theodore R Holford; Elizabeth A Holly; Brian C H Chiu; Paolo Vineis; Emanuele Stagnaro; Eleanor V Willett; Silvia Franceschi; Carlo La Vecchia; Ann Maree Hughes; Wendy Cozen; Scott Davis; Richard K Severson; Leslie Bernstein; Susan T Mayne; Fred R Dee; James R Cerhan; Tongzhang Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

3.  Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.

Authors:  Manuela Gago-Dominguez; Douglas A Bell; Mary A Watson; Jian-Min Yuan; J Esteban Castelao; David W Hein; Kenneth K Chan; Gerhard A Coetzee; Ronald K Ross; Mimi C Yu
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

4.  Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women.

Authors:  S Zhang; D J Hunter; B A Rosner; G A Colditz; C S Fuchs; F E Speizer; W C Willett
Journal:  J Natl Cancer Inst       Date:  1999-10-20       Impact factor: 13.506

Review 5.  Genotoxicity of heat-processed foods.

Authors:  Margaretha Jägerstad; Kerstin Skog
Journal:  Mutat Res       Date:  2005-04-01       Impact factor: 2.433

6.  Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.

Authors:  Nilanjan Chatterjee; Patricia Hartge; James R Cerhan; Wendy Cozen; Scott Davis; Naoko Ishibe; Joanne Colt; Lynn Goldin; Richard K Severson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

Review 7.  Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.

Authors:  David W Hein
Journal:  Mutat Res       Date:  2002-09-30       Impact factor: 2.433

8.  Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay.

Authors:  E De Stefani; L Fierro; E Barrios; A Ronco
Journal:  Leuk Res       Date:  1998-05       Impact factor: 3.156

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Diet and risk of non-Hodgkin lymphoma in older women.

Authors:  B C Chiu; J R Cerhan; A R Folsom; T A Sellers; L H Kushi; R B Wallace; W Zheng; J D Potter
Journal:  JAMA       Date:  1996-05-01       Impact factor: 56.272

View more
  23 in total

1.  NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.

Authors:  Lori M Millner; Mark A Doll; Jian Cai; J Christopher States; David W Hein
Journal:  Mol Carcinog       Date:  2011-08-11       Impact factor: 4.784

2.  Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.

Authors:  Lori M Millner; Mark A Doll; Jian Cai; J Christopher States; David W Hein
Journal:  Drug Metab Dispos       Date:  2011-10-18       Impact factor: 3.922

3.  Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.

Authors:  Yawei Zhang; Kathryn J Hughes; Shelia Hoar Zahm; Yaqun Zhang; Theodore R Holford; Li Dai; Yana Bai; Xuesong Han; Qin Qin; Qing Lan; Nathaniel Rothman; Yong Zhu; Brian Leaderer; Tongzhang Zheng
Journal:  Am J Epidemiol       Date:  2009-10-12       Impact factor: 4.897

Review 4.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

5.  Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.

Authors:  Xuesong Han; Tongzhang Zheng; Francine M Foss; Qing Lan; Theodore R Holford; Nathaniel Rothman; Shuangge Ma; Yawei Zhang
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

6.  Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.

Authors:  Todd M Gibson; Karin E Smedby; Christine F Skibola; David W Hein; Susan L Slager; Silvia de Sanjosé; Claire M Vajdic; Yawei Zhang; Brian C-H Chiu; Sophia S Wang; Henrik Hjalgrim; Alexandra Nieters; Paige M Bracci; Anne Kricker; Tongzhang Zheng; Carol Kolar; James R Cerhan; Hatef Darabi; Nikolaus Becker; Lucia Conde; Theodore R Holford; Dennis D Weisenburger; Anneclaire J De Roos; Katja Butterbach; Jacques Riby; Wendy Cozen; Yolanda Benavente; Casey Palmers; Elizabeth A Holly; Joshua N Sampson; Nathaniel Rothman; Bruce K Armstrong; Lindsay M Morton
Journal:  Cancer Causes Control       Date:  2012-11-18       Impact factor: 2.506

7.  Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.

Authors:  Linda E Kelemen; Sophia S Wang; Unhee Lim; Wendy Cozen; Maryjean Schenk; Patricia Hartge; Yan Li; Nathaniel Rothman; Scott Davis; Stephen J Chanock; Mary H Ward; James R Cerhan
Journal:  Cancer Causes Control       Date:  2008-01-17       Impact factor: 2.506

8.  Mining mammalian transcript data for functional long non-coding RNAs.

Authors:  Amit N Khachane; Paul M Harrison
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

9.  Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.

Authors:  Neera Singh; Sudhisha Dubey; Saravanan Chinnaraj; Anil Golani; Anurupa Maitra
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

Authors:  Lindsay M Morton; Sophia S Wang; Wendy Cozen; Martha S Linet; Nilanjan Chatterjee; Scott Davis; Richard K Severson; Joanne S Colt; Mohammad A Vasef; Nathaniel Rothman; Aaron Blair; Leslie Bernstein; Amanda J Cross; Anneclaire J De Roos; Eric A Engels; David W Hein; Deirdre A Hill; Linda E Kelemen; Unhee Lim; Charles F Lynch; Maryjean Schenk; Sholom Wacholder; Mary H Ward; Shelia Hoar Zahm; Stephen J Chanock; James R Cerhan; Patricia Hartge
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.